Achilles Therapeutics PLC Analysis
| ACHLDelisted Stock | USD 1.48 0.00 0.00% |
Achilles Therapeutics PLC is overvalued with Real Value of 1.15 and Hype Value of 1.48. The main objective of Achilles Therapeutics delisted stock analysis is to determine its intrinsic value, which is an estimate of what Achilles Therapeutics PLC is worth, separate from its market price. There are two main types of Achilles Therapeutics' stock analysis: fundamental analysis and technical analysis.
The Achilles Therapeutics stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
Achilles |
Achilles Stock Analysis Notes
About 83.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.59. Some equities with similar Price to Book (P/B) outperform the market in the long run. Achilles Therapeutics PLC recorded a loss per share of 1.66. The entity had not issued any dividends in recent years. Achilles Therapeutics Plc, a clinical stage immuno-oncology biopharmaceutical company, develops precision T cell therapies to treat various solid tumors. The company was founded in 2016 and is headquartered in London, the United Kingdom. Achilles Therapeutics is traded on NASDAQ Exchange in the United States. For more info on Achilles Therapeutics PLC please contact Iraj Ali at 44 20 8154 4600 or go to https://www.achillestx.com.Achilles Therapeutics PLC Investment Alerts
| Achilles Therapeutics is not yet fully synchronised with the market data | |
| Achilles Therapeutics may become a speculative penny stock | |
| Achilles Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| Achilles is showing solid risk-adjusted performance over 90 days | |
| Net Loss for the year was (69.94 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Achilles Therapeutics PLC currently holds about 201.6 M in cash with (48.45 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.94, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Over 83.0% of the company shares are held by institutions such as insurance companies |
Achilles Therapeutics PLC Upcoming and Recent Events
| 5th of March 2024 Upcoming Quarterly Report | View | |
| 8th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 5th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Achilles Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 63.22 M.Achilles Therapeutics Outstanding Bonds
Achilles Therapeutics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Achilles Therapeutics PLC uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Achilles bonds can be classified according to their maturity, which is the date when Achilles Therapeutics PLC has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| ACE INA HLDGS Corp BondUS00440EAH09 | View | |
| ACE INA HLDGS Corp BondUS00440EAQ08 | View | |
| ACE INA HLDGS Corp BondUS00440EAW75 | View | |
| ACE INA HLDGS Corp BondUS00440EAV92 | View | |
| ACI Worldwide 575 Corp BondUS004498AB73 | View | |
| ACE CAP TR Corp BondUS00440FAA21 | View |
Achilles Therapeutics Predictive Daily Indicators
Achilles Therapeutics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Achilles Therapeutics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
About Achilles Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Achilles Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Achilles shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as Achilles Therapeutics. By using and applying Achilles Stock analysis, traders can create a robust methodology for identifying Achilles entry and exit points for their positions.
Achilles Therapeutics Plc, a clinical stage immuno-oncology biopharmaceutical company, develops precision T cell therapies to treat various solid tumors. The company was founded in 2016 and is headquartered in London, the United Kingdom. Achilles Therapeutics is traded on NASDAQ Exchange in the United States.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Achilles Therapeutics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Center Now
Portfolio CenterAll portfolio management and optimization tools to improve performance of your portfolios |
| All Next | Launch Module |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Consideration for investing in Achilles Stock
If you are still planning to invest in Achilles Therapeutics PLC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Achilles Therapeutics' history and understand the potential risks before investing.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |